PMID- 25243785
OWN - NLM
STAT- MEDLINE
DCOM- 20150219
LR  - 20220316
IS  - 1539-3704 (Electronic)
IS  - 0003-4819 (Linking)
VI  - 161
IP  - 12
DP  - 2014 Dec 16
TI  - Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force 
      recommendation statement.
PG  - 902-10
LID - 10.7326/M14-1981 [doi]
AB  - DESCRIPTION: Update of previous U.S. Preventive Services Task Force (USPSTF) 
      recommendations on screening for chlamydia (2007) and gonorrhea (2005). METHODS: 
      The USPSTF reviewed the evidence on screening for chlamydial and gonococcal 
      infections in asymptomatic patients from studies published since its last 
      reviews. The USPSTF also considered evidence from its previous recommendations 
      and reviews. POPULATION: This recommendation applies to all sexually active 
      adolescents and adults, including pregnant women. RECOMMENDATIONS: The USPSTF 
      recommends screening for chlamydia in sexually active females aged 24 years or 
      younger and in older women who are at increased risk for infection. (B 
      recommendation) The USPSTF recommends screening for gonorrhea in sexually active 
      females aged 24 years or younger and in older women who are at increased risk for 
      infection. (B recommendation) The USPSTF concludes that the current evidence is 
      insufficient to assess the balance of benefits and harms of screening for 
      chlamydia and gonorrhea in men. (I statement).
FAU - LeFevre, Michael L
AU  - LeFevre ML
CN  - U.S. Preventive Services Task Force
LA  - eng
PT  - Journal Article
PT  - Practice Guideline
PL  - United States
TA  - Ann Intern Med
JT  - Annals of internal medicine
JID - 0372351
RN  - 0 (Anti-Bacterial Agents)
SB  - IM
SPIN- Ann Intern Med. 2014 Dec 16;161(12):I-30. PMID: 25243662
MH  - Adolescent
MH  - Adult
MH  - Anti-Bacterial Agents/therapeutic use
MH  - Asymptomatic Diseases
MH  - Bacteriological Techniques
MH  - Biomedical Research
MH  - Chlamydia Infections/*diagnosis/drug therapy/economics/prevention & control
MH  - Early Diagnosis
MH  - Female
MH  - Gonorrhea/*diagnosis/drug therapy/economics/prevention & control
MH  - Health Care Costs
MH  - Humans
MH  - Male
MH  - *Mass Screening/adverse effects
MH  - Nucleic Acid Amplification Techniques
MH  - Pregnancy
MH  - Risk Factors
MH  - United States
MH  - Young Adult
FIR - LeFevre, Michael L
IR  - LeFevre ML
FIR - Siu, Albert L
IR  - Siu AL
FIR - Peters, James J
IR  - Peters JJ
FIR - Bibbins-Domingo, Kirsten
IR  - Bibbins-Domingo K
FIR - Baumann, Linda Ciofu
IR  - Baumann LC
FIR - Curry, Susan J
IR  - Curry SJ
FIR - Davidson, Karina W
IR  - Davidson KW
FIR - Ebell, Mark
IR  - Ebell M
FIR - Garc a, Francisco A R
IR  - Garc a FA
FIR - Gillman, Matthew
IR  - Gillman M
FIR - Herzstein, Jessica
IR  - Herzstein J
FIR - Kemper, Alex R
IR  - Kemper AR
FIR - Kurth, Ann E
IR  - Kurth AE
FIR - Owens, Douglas K
IR  - Owens DK
FIR - Phillips, William R
IR  - Phillips WR
FIR - Phipps, Maureen G
IR  - Phipps MG
FIR - Pignone, Michael P
IR  - Pignone MP
EDAT- 2014/09/23 06:00
MHDA- 2015/02/20 06:00
CRDT- 2014/09/23 06:00
PHST- 2014/09/23 06:00 [entrez]
PHST- 2014/09/23 06:00 [pubmed]
PHST- 2015/02/20 06:00 [medline]
AID - 1906843 [pii]
AID - 10.7326/M14-1981 [doi]
PST - ppublish
SO  - Ann Intern Med. 2014 Dec 16;161(12):902-10. doi: 10.7326/M14-1981.